17 Sessions  PREVNEXT

  • Main Hall
    1F
  • Sakura
    1F
  • Annex 1
    1F
  • Annex 2
    1F
  • Room A
    2F
  • Room B1
    2F
  • Room B2
    2F
  • Room D
    1F
  • Room E
    1F
8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 22:00

08:30

PaulE.M.Phillips{PHILLIPSPAULE.M.}|KozoKaibuchi{KAIBUCHIKOZO}|HaruoKasai{KASAIHARUO}|Ming-HuHan{HANMING-HU}____Symposium 72
Novel regulations and functions of dopaminergic systems towards understanding psychiatric disorders|1|3|TomoyukiFuruyashiki{FURUYASHIKITOMOYUKI}|PaulE.M.Phillips{PHILLIPSPAULE.M.}____LaurenM.Burgeno{BURGENOLAURENM.}|RyanD.Farero{FARERORYAND.}|NicoleL.Murray{MURRAYNICOLEL.}|JenniferS.Steger{STEGERJENNIFERS.}|MartaE.Soden{SODENMARTAE.}|IngoWilluhn{WILLUHNINGO}|LarryS.Zweifel{ZWEIFELLARRYS.}|YasuhiroFunahashi{FUNAHASHIYASUHIRO}|AnthonyAriza{ARIZAANTHONY}|KeisukeKuroda{KURODAKEISUKE}|TakuNagai{NAGAITAKU}|KiyofumiYamada{YAMADAKIYOFUMI}|YusukeIino{IINOYUSUKE}|RyosukeNakazato{NAKAZATORYOSUKE}|KenjiYamaguchi{YAMAGUCHIKENJI}|TakeshiSawada{SAWADATAKESHI}|ShoYagishita{YAGISHITASHO}|HongxingZhang{ZHANGHONGXING}|DipeshChaudhury{CHAUDHURYDIPESH}|AlexanderRNectow{NECTOWALEXANDERR}|SongZhang{ZHANGSONG}|BarbaraJuarez{JUAREZBARBARA}|AllysonKFriedman{FRIEDMANALLYSONK}|JeffreyMFriedman{FRIEDMANJEFFREYM}|Jun-LiCao{CAOJUN-LI}

S116

Symposium 72
Novel regulations and functions of dopaminergic sys...

10:20

RobertC.Speth{SPETHROBERTC.}|KouichiTamura{TAMURAKOUICHI}|PaulJ.Marvar{MARVARPAULJ.}|UrsulaQuitterer{QUITTERERURSULA}____Symposium 73
New perspectives on the function and pharmacology of the renin-angiotensin system|1|3|SClareStanford{STANFORDSCLARE}|KouichiTamura{TAMURAKOUICHI}____HongWPang{PANGHONGW}|ChristopherTNeagra{NEAGRACHRISTOPHERT}|SamanthaBergoine{BERGOINESAMANTHA}|FiliipeFStoyell-Conti{STOYELL-CONTIFILIIPEF}|KohjiOhki{OHKIKOHJI}|KengoAzushima{AZUSHIMAKENGO}|KazushiUneda{UNEDAKAZUSHI}|RyuKobayashi{KOBAYASHIRYU}|ShoKinguchi{KINGUCHISHO}|KotaroHaruhara{HARUHARAKOTARO}|TakahiroYamaji{YAMAJITAKAHIRO}|TakayukiYamada{YAMADATAKAYUKI}|HiromichiWakui{WAKUIHIROMICHI}|AndreasLanger{LANGERANDREAS}|SaidAbdalla{ABDALLASAID}

S117

Symposium 73
New perspectives on the function and pharmacology o...

08:30

KimikoYamamoto{YAMAMOTOKIMIKO}|NaokiMochizuki{MOCHIZUKINAOKI}|StefanOffermanns{OFFERMANNSSTEFAN}____Symposium 74
Endothelial Mechanosensing in Vascular Physiology and Disease|1|4|NaokiMochizuki{MOCHIZUKINAOKI}|StefanOffermanns{OFFERMANNSSTEFAN}____JojiAndo{ANDOJOJI}|HiroyukiNakajima{NAKAJIMAHIROYUKI}

S118

Symposium 74
Endothelial Mechanosensing in Vascular Physiology a...

10:20

DavidJ.Beech{BEECHDAVIDJ.}|StefanFeske{FESKESTEFAN}|YasuoMori{MORIYASUO}|SusanD.Brain{BRAINSUSAND.}____Symposium 75
Cutting edge of calcium permeable ion channels in diseases as potential targets of drug discovery|1|4|YujiImaizumi{IMAIZUMIYUJI}|DavidJ.Beech{BEECHDAVIDJ.}____

S119

Symposium 75
Cutting edge of calcium permeable ion channels in d...

08:30

ChrisGoldring{GOLDRINGCHRIS}|AnnK.Daly{DALYANNK.}|TsuyoshiYokoi{YOKOITSUYOSHI}____Symposium 76
Novel biomarkers, predictors and models for drug-induced liver injury|1|27|ChrisGoldring{GOLDRINGCHRIS}|AnnK.Daly{DALYANNK.}____

S120

Symposium 76
Novel biomarkers, predictors and models for drug-in...

10:20

BarbaraF.Hales{HALESBARBARAF.}|JunKanno{KANNOJUN}|JosC.Kleinjans{KLEINJANSJOSC.}|HiroakiKitano{KITANOHIROAKI}____Symposium 77
Toxicogenomics for accelerated and refined hazard identification of chemicals|1|27|JosC.Kleinjans{KLEINJANSJOSC.}|HiroakiKitano{KITANOHIROAKI}____BernardRobaire{ROBAIREBERNARD}|SatoshiKitajima{KITAJIMASATOSHI}|Ken-IchiAisaki{AISAKIKEN-ICHI}

S121

Symposium 77
Toxicogenomics for accelerated and refined hazard i...

08:30

EickeLatz{LATZEICKE}|MarcoColonna{COLONNAMARCO}|OsamuTakeuchi{TAKEUCHIOSAMU}|SatoshiUematsu{UEMATSUSATOSHI}____Symposium 78
Immunology and Inflammation|1|21|SatoshiUematsu{UEMATSUSATOSHI}|MarcoColonna{COLONNAMARCO}____OliviaKoues{KOUESOLIVIA}|PatrickCollins{COLLINSPATRICK}|MarinaCella{CELLAMARINA}|MichelleRobinette{ROBINETTEMICHELLE}|GeneOltz{OLTZGENE}

S122

Symposium 78
Immunology and Inflammation

10:20

FrancescaLevi-Schaffer{LEVI-SCHAFFERFRANCESCA}|SantiagoP.MendezHuergo{MENDEZHUERGOSANTIAGOP.}|MauroM.Teixeira{TEIXEIRAMAUROM.}|KazuyoMoro{MOROKAZUYO}____Symposium 79
New Controllers of Inflammation: What are the hottest targets?|1|21|FrancescaLevi-Schaffer{LEVI-SCHAFFERFRANCESCA}|MauroM.Teixeira{TEIXEIRAMAUROM.}____GabrielA.Rabinovich{RABINOVICHGABRIELA.}|VanessaPinho{PINHOVANESSA}|LirlandiaPSousa{SOUSALIRLANDIAP}|VivianVCosta{COSTAVIVIANV}

S123

Symposium 79
New Controllers of Inflammation: What are the hotte...

08:30

RamanujDasGupta{DASGUPTARAMANUJ}|AlastairG.Stewart{STEWARTALASTAIRG.}|ChweeTeckLim{LIMCHWEETECK}|HiroshiKimura{KIMURAHIROSHI}____Symposium 80
3D microtissues in drug discovery: Mechanopharmacology|1|9|ChweeTeckLim{LIMCHWEETECK}|RamanujDasGupta{DASGUPTARAMANUJ}____AsresBerhan{BERHANASRES}|FernandoJGuzman{GUZMANFERNANDOJ}|PeterVLee{LEEPETERV}|TrudiHarris{HARRISTRUDI}|QianyuChen{CHENQIANYU}|BeeLuanKhoo{KHOOBEELUAN}|TeruoFujii{FUJIITERUO}

S124

Symposium 80
3D microtissues in drug discovery: Mechanopharmacology

10:20

AnnekeC.Hesseling{HESSELINGANNEKEC.}|ThomasP.C.Dorlo{DORLOTHOMASP.C.}|HelenMcilleron{MCILLERONHELEN}|LarsL.Gustafsson{GUSTAFSSONLARSL.}____Symposium 81
Optimising drug selection and dosage in treating infectious diseases in children and pregnant women in Africa|1|17|LarsL.Gustafsson{GUSTAFSSONLARSL.}|HelenMcilleron{MCILLERONHELEN}____JaranEriksen{ERIKSENJARAN}|SarahNanzigu{NANZIGUSARAH}|LarsNaver{NAVERLARS}|JohannaRubin{RUBINJOHANNA}|SandraSoeria-Atmadja{SOERIA-ATMADJASANDRA}

S125

Symposium 81
Optimising drug selection and dosage in treating in...

08:30

AtsushiMiyawaki{MIYAWAKIATSUSHI}|MichelleL.Halls{HALLSMICHELLEL.}|StephenJ.Hill{HILLSTEPHENJ.}|CarlWhite{WHITECARL}____Symposium 82
Cutting edge assay technologies for studying molecular and cellular pharmacology (Joint Symposium between BPS and ASCPT)|1|9|KevinPfleger{PFLEGERKEVIN}|MichelleL.Halls{HALLSMICHELLEL.}____

S126

Symposium 82
Cutting edge assay technologies for studying molecu...

10:20

GrahameHardie{HARDIEGRAHAME}|KeiSakamoto{SAKAMOTOKEI}|SandraGalic{GALICSANDRA}|A.MarkEvans{EVANSA.MARK}____Symposium 83
System pharmacology of the AMPK-activated protein kinase|1|9|A.MarkEvans{EVANSA.MARK}|GrahameHardie{HARDIEGRAHAME}____KimLoh{LOHKIM}|BruceEKemp{KEMPBRUCEE}|GregoryRSteinberg{STEINBERGGREGORYR}

S127

Symposium 83
System pharmacology of the AMPK-activated protein k...

08:30

JoanHellerBrown{BROWNJOANHELLER}|MikitoTakefuji{TAKEFUJIMIKITO}|ShigekiMiyamoto{MIYAMOTOSHIGEKI}|RichardR.Neubig{NEUBIGRICHARDR.}|HiroakiShimokawa{SHIMOKAWAHIROAKI}____Symposium 84
GPCR and RhoA Signaling in Physiology and Disease|1|1|JoanHellerBrown{BROWNJOANHELLER}|ShigekiMiyamoto{MIYAMOTOSHIGEKI}____ShigekiMiyamoto{MIYAMOTOSHIGEKI}|JorgeBenitez{BENITEZJORGE}|FrankFurnari{FURNARIFRANK}|OliviaYu{YUOLIVIA}|OlgaChaim{CHAIMOLGA}|StefanOffermanns{OFFERMANNSSTEFAN}|KozoKaibuchi{KAIBUCHIKOZO}|ToyoakiMurohara{MUROHARATOYOAKI}|ValeriePTan{TANVALERIEP}|JeffreyMSmith{SMITHJEFFREYM}|JoanHBrown{BROWNJOANH}|ErikaM.Lisabeth{LISABETHERIKAM.}|DylanKahl{KAHLDYLAN}|SarahHaynes{HAYNESSARAH}|BrentMartin{MARTINBRENT}|ScottD.Larsen{LARSENSCOTTD.}

S128

Symposium 84
GPCR and RhoA Signaling in Physiology and Disease

10:20

AnthonyP.Davenport{DAVENPORTANTHONYP.}|AndrewB.Tobin{TOBINANDREWB.}|MartinJ.Lohse{LOHSEMARTINJ.}|LauraM.Bohn{BOHNLAURAM.}____Symposium 85
Biased agonism at G protein-coupled receptors: The promise and the challenges|1|1|AnthonyP.Davenport{DAVENPORTANTHONYP.}|ChristopherJ.Langmead{LANGMEADCHRISTOPHERJ.}____PeiranYang{YANGPEIRAN}|CaiRead{READCAI}|DuuameneNyimanu{NYIMANUDUUAMENE}|TomWilliams{WILLIAMSTOM}|PetraSulentic{SULENTICPETRA}|RhodaKuc{KUCRHODA}|StefanGraf{GRAFSTEFAN}|NicholasMorrell{MORRELLNICHOLAS}|JanetMaguire{MAGUIREJANET}

S129

Symposium 85
Biased agonism at G protein-coupled receptors: The ...

08:30

DayueDarrelDuan{DUANDAYUEDARREL}|WenxiaZhou{ZHOUWENXIA}|LunYang{YANGLUN}|ThomasEfferth{EFFERTHTHOMAS}____Symposium 86
Network pharmacology|1|20|WenxiaZhou{ZHOUWENXIA}|ThomasEfferth{EFFERTHTHOMAS}____LingyuLindaYe{YELINGYULINDA}|Si-jinYang{YANGSI-JIN}|JianhuiWang{WANGJIANHUI}|YanHuang{HUANGYAN}|LuHan{HANLU}|XiaoruiCheng{CHENGXIAORUI}|YongxiangZhang{ZHANGYONGXIANG}

S130

Symposium 86
Network pharmacology

10:20

KonstantinosKonstantopoulos{KONSTANTOPOULOSKONSTANTINOS}|AntonioFrigeri{FRIGERIANTONIO}|MarikoHara-Chikuma{HARA-CHIKUMAMARIKO}|Tae-HwanKwon{KWONTAE-HWAN}____Symposium 87
New insight into aquaporin function as drug targets|1|9|MasatoYasui{YASUIMASATO}|AntonioFrigeri{FRIGERIANTONIO}____SeanXSun{SUNSEANX}|NicchiaGPaola{PAOLANICCHIAG}

S131

Symposium 87
New insight into aquaporin function as drug targets

12:10

-____Closing Ceremony|1|1|-____

TABLE043

Closing Ceremony

Advanced Search